The CEO of Germany’s BioNTech outearned all his fellow pharma CEOs in 2024, according to Fierce Pharma. Dr. Uğur Şahin’s nine-figure salary — $287 million — rocketed him to the top of the industry publication’s list of highest-paid CEOs.
Eli Lilly’s CEO, David Ricks, shot to second on the list with $29.2 million in total compensation. Eli Lilly makes the weight loss blockbuster drugs Zepbound and Mounjaro, which rival Novo Nordisk’s Ozempic and Wegovy. In July, Eli Lilly will start selling the drugs online at discounted prices directly to consumers who have a prescription.
The Fierce Pharma list included other executives from some of the top vaccine manufacturers. Pfizer CEO Albert Bourla ranked third, with a total compensation of $24.6 million — his second-highest annual salary after his $33 million payout in 2022, when Pfizer was reaping massive profits from its COVID-19 vaccine and its antiviral Paxlovid.
The CEOs of Johnson & Johnson and AstraZeneca also made the list, even after the disastrous outcomes for their COVID-19 vaccines. Johnson & Johnson’s shot, associated with serious and life-threatening blood clots, is no longer available in the U.S...
READ FULL ARTICLE HERE… (childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Be First to Comment